Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v32-EN Version v4-FR
Language English French
Date Updated 2024-01-18 2023-02-08
Drug Identification Number 02519089 02519089
Brand name DIASTAT DIASTAT
Common or Proper name DIASTAT DIASTAT
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients DIAZEPAM DIAZEPAM
Strength(s) 15MG 15MG
Dosage form(s) GEL GEL
Route of administration RECTAL RECTAL
Packaging size 2pk 2pk
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-02-10 2023-02-10
Actual start date 2023-02-14
Estimated end date 2024-01-19 2023-04-30
Actual end date 2024-01-17
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments